Sun Pharma Unveils Promising Developments at AAD Annual Meeting
Sun Pharma presented significant findings at the 2026 AAD Annual Meeting, focusing on advancements in dermatology and immunology.
Sun Pharma presented significant findings at the 2026 AAD Annual Meeting, focusing on advancements in dermatology and immunology.
IOL Chemicals & Pharmaceuticals Ltd has seen a notable decline in its stock price, raising questions about its future performance. This article delves into the recent market trends.
The Nikkei 225 has rebounded, closing up 0.97% as the pharma and metals sectors showed strong performance. However, volatility remains a concern.
The Nikkei 225 saw a significant rebound, rising 0.97% to 52,017, driven by strong performances in the pharmaceutical and metals sectors.
A major counterfeit drug network was dismantled in Delhi, involving Tanishq Jha and several others, with police seizing drugs worth nearly Rs 50 crore.